You could be right... The only issue is that other biotechs are killing it with massive moves so this is more of a laggard than a value trap. It could get even cheaper since it does not meet the criteria of a monster mover - time will confirm that.
Here are SOME other stocks 99% of investors missed when they started moving a few months back (starting with some pharma / Biotech); REGN, INFI, CLSN, SRPT, ARNA, DYAX, SNTS, NTE, DDD, SHW, SIRI, PHM, V, CVI, CONN, PSX and TASR just to mention a few...
If YOU ever get tired of watching your stocks lose YOU money then consider :m:u:a:t:h:e: . :c:o:m: (without the colons).